Skip to main content
Top

Drugs

Issue 10/2024

Content (12 Articles)

Dose Individualisation of Antimicrobials from a Pharmacometric Standpoint: The Current Landscape

Tim Preijers, Anouk E. Muller, Alan Abdulla, Brenda C. M. de Winter, Birgit C. P. Koch, Sebastiaan D. T. Sassen

Targeting the Sphingosine-1-Phosphate Pathway: New Opportunities in Inflammatory Bowel Disease Management

Konstantina Kitsou, Georgios Kokkotis, Jesús Rivera‑Nieves, Giorgos Bamias

Anticoagulation in Chronic Kidney Disease

Marco Montomoli, Boris Gonzales Candía, Adriana Acosta Barrios, Elisa Perez Bernat

Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination

George G. Zhanel, Celine Mansour, Stacey Mikolayanko, Courtney K. Lawrence, Sheryl Zelenitsky, Danyel Ramirez, Frank Schweizer, Denice Bay, Heather Adam, Philippe Lagacé-Wiens, Andrew Walkty, Neal Irfan, Nina Clark, David Nicolau, Carlo Tascini, James A. Karlowsky

Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences

Mario Cazzola, Clive P. Page, Nicola A. Hanania, Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani

Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis

Dominique P. M. S. M. Maas, Loes H. Willems, Josephine Kranendonk, Cornelis Kramers, Michiel C. Warlé

Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials

  • Open Access
  • Timolol
  • Original Research Article

I. Paul Singh, John P. Berdahl, Steven R. Sarkisian Jr, Lilit A. Voskanyan, Robert E. Ang, Long V. Doan, David Applegate, Yannan Shen, L. Jay Katz, Angela C. Kothe, Tomas Navratil

Donanemab: First Approval

Connie Kang

Golidocitinib: First Approval

  • NSCLC
  • AdisInsight Report

Susan J. Keam

Vorasidenib: First Approval

  • Open Access
  • Glioma
  • AdisInsight Report

Yvette N. Lamb

Correction: Donanemab: First Approval

  • Correction

Connie Kang

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images